A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity

NCT03320941 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

126

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: LIK066
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals